April 16, 2024

Asthma Cooperative Agreement Partner Profile – Utah

CDC is funding the health departments in California, Connecticut, Florida, Georgia, Houston, Illinois, Indiana, Kentucky, Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, New Hampshire, New Mexico, New York, Ohio, Pennsylvania, Puerto Rico, Rhode Island, Texas, Utah, Vermont, and Wisconsin to improve the reach, quality, effectiveness, and sustainability of asthma control services and to reduce asthma morbidity, mortality and disparities by implementing evidence-based strategies.

Overview

The Utah Asthma Program (UAP) has been part of CDC's National Asthma Control Program since 2001. The UAP works alongside partners to improve the quality of asthma care, improve asthma management in schools, and foster policies to help reduce exposure to asthma triggers in outdoor, indoor, and workplace environments.

Grantee

Utah Department of Health

Contact

Nichole Shepard, MPH

Telephone

(801) 538-6259

E-mail

nshepard@utah.gov

Address

Asthma Program Bureau of Health Promotion
Utah Department of Health
P.O. Box 142106
Salt Lake City, UT 84114-2106

Websites

Utah Asthma Program

Data Profile

Asthma in Utah

Grantee Profile

ACAPP - Utah

Highlights

UAP launched the Utah Asthma Home Visiting Program (UAHVP) in January 2016. The program consists of three visits and two follow-up phone calls. The UAHVP serves families with uncontrolled asthma by training and sending local health department (LHD) personnel into homes to provide asthma self-management education, trigger assessment and reduction, and referrals to healthcare providers or home remediation services. Salt Lake County, Utah County, and Southeast Utah LHDs implement the UAHVP, collaborating with UAP to evaluate program performance and conduct quality improvement activities. In 2022, about 58% of those who had uncontrolled asthma at the first visit achieved control by a 12-month follow-up visit, and 61% showed improvement in their Asthma Control Test (ACT) score from the first visit to a 6-month follow-up visit. All participants (100%) agreed that the UAHVP would improve their quality of life. UAP has supported the LHDs in adapting the UAHVP to accommodate a virtual visiting format since 2020.

Since 2014, UAP and the Utah Pediatric Partnership to Improve Healthcare Quality have successfully recruited and guided 37 clinics to improve primary care diagnosis and team-based management of patients with asthma. Clinics participate in a 6-month learning collaborative to improve guidelines-based asthma care practices. A 2022 evaluation showed that participating clinics improved in many areas, including an increase in asthma assessments using a standardized tool (ACT) from 38% to 90% and an increase in patients with a current asthma action plan/self-management plan on file from 55% to 100%.

The UAP promotes air quality guidance to address public concerns about poor air quality, including winter inversions, summer ozone, and wildfire smoke. UAP worked with the Utah Department of Environmental Quality and the Asthma Task Force in 2016 to update the Utah Recess Guidance, which provides recommendations for school personnel on when to hold recess indoors on poor air quality days. UAP continues to maintain an air quality listserv to provide particulate alerts, sending emails to 325 schools on days when students should remain indoors. In 2021, as part of a multi-department quality improvement project, the UAP began to explore automation of Recess Guidance email alerts, selecting an email automation platform to provide targeted alerts by county.

The Utah Asthma Task Force collaborated with the UAP on a workgroup concerning a stock albuterol policy in Utah starting in late 2018. The stock albuterol law passed unanimously in the 2019 legislative session, allowing Utah schools to keep stock albuterol and administer it to students in case of an emergency. The UAP further collaborated with additional partners, including the Utah Department of Health and Human Services School Nurse Liaison, to prepare guidelines and data collection forms for the implementation of the policy in July 2020. In 2022, an evaluation of stock albuterol identified key barriers to implementing the initiative, including finding a provider to write the prescription, finding a pharmacy to fill the prescription, and costs to acquire the medication.